Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2259608
Apr 22, 2024 - Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
0
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001
Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
0
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001
Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
0